![Western Blot: ASCIZ Antibody [NBP2-81796] - Analysis of ASCIZ in 293 cell lysate with ASCIZ antibody at (A) 1 and (B) 2 ug/ml.](http://images.novusbio.com/fullsize/ASCIZ-Antibody-Western-Blot-NBP2-81796-img0001.jpg "Western Blot: ASCIZ Antibody [NBP2-81796] - Analysis of ASCIZ in 293 cell lysate with ASCIZ antibody at (A) 1 and (B) 2 ug/ml.")
| Reactivity | Hu, Mu, RtSpecies Glossary |
| Applications | WB, ELISA, ICC/IF |
| Clonality | Polyclonal |
| Host | Rabbit |
| Conjugate | Unconjugated |
| Format | BSA Free |
| Concentration | 1 mg/ml |
| Immunogen | ASCIZ antibody was raised against a 19 amino acid peptide near the amino terminus of human ASCIZ. The immunogen is located within amino acids 200 - 250 of ASCIZ. Amino Acid Squence: HEIPAEHRDPPSKKRKMEN |
| Specificity | ASCIZ antibody is human, mouse and rat reactive. At least three isoforms of ASCIZ are known to exist. |
| Isotype | IgG |
| Clonality | Polyclonal |
| Host | Rabbit |
| Gene | ATMIN |
| Purity | Peptide affinity purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Dilutions |
|
| Theoretical MW | 72 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
| Storage | Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
| Buffer | PBS |
| Preservative | 0.02% Sodium Azide |
| Concentration | 1 mg/ml |
| Purity | Peptide affinity purified |
Secondary Antibodies |
Isotype Controls |
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
| Gene Symbol | ATMIN |
![Immunocytochemistry/Immunofluorescence: ASCIZ Antibody [NBP2-81796] - Immunofluorescence of ASCIZ in A431 cells with ASCIZ antibody at 2.5 ug/mL.](http://images.novusbio.com/fullsize/ASCIZ-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-81796-img0003.jpg "Immunocytochemistry/Immunofluorescence: ASCIZ Antibody [NBP2-81796] - Immunofluorescence of ASCIZ in A431 cells with ASCIZ antibody at 2.5 ug/mL.")
![Immunocytochemistry/Immunofluorescence: ASCIZ Antibody [NBP2-81796] - Immunocytochemistry of ASCIZ in A431 cells with ASCIZ antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/ASCIZ-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-81796-img0002.jpg "Immunocytochemistry/Immunofluorescence: ASCIZ Antibody [NBP2-81796] - Immunocytochemistry of ASCIZ in A431 cells with ASCIZ antibody at 5 ug/mL.")
![PIN/DLC8 Antibody [Unconjugated]](/sites/all/modules/enterprise-tech/et_datasheets/images/novus_guarantee.png "PIN/DLC8 Antibody [Unconjugated]")
![Western Blot Chk2 [p Thr68] Antibody [Unconjugated]](https://images.novusbio.com/images2/Chk2_AF1626_Western_Blot_5130.jpg)
![Immunocytochemistry Chk2 [p Thr68] Antibody [Unconjugated]](https://images.novusbio.com/images2/Chk2_AF1626_Immunocytochemistry__Immunofluorescence_18847.jpg)
![SDS-PAGE FGF-10 [Unconjugated]](https://images.novusbio.com/images2/FGF-10_345-FG_557.jpg)
![Bioactivity FGF-10 [Unconjugated]](https://images.novusbio.com/images2/FGF-10_345-FG_559.jpg)
![Bioactivity FGF-10 [Unconjugated]](https://images.novusbio.com/images/345-fg_recombinant-human-fgf-10-protein-bioactivity-2520239220..jpg)
![Neutralization Artemin Antibody [Unconjugated]](https://images.novusbio.com/images2/Artemin_AF1085_Block_Neutralize_8756.jpg)
![Western Blot CIB1 Antibody (791119) [Unconjugated]](https://images.novusbio.com/images2/CIB1_MAB7557_Western_Blot_13865.jpg)
![Immunohistochemistry CIB1 Antibody (791119) [Unconjugated]](https://images.novusbio.com/images2/CIB1_MAB7557_Immunohistochemistry_13917.jpg)
![Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).](https://images.novusbio.com/images/Goat-anti-Rabbit-IgG-H+L-Secondary-Antibody-HRP-Western-Blot-NB7160-img0001.jpg "Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).")
![Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.](https://images.novusbio.com/images/Rabbit--Mouse-IgG-Isotype-Control-Flow-Cytometry-NBP2-24891-img0001.jpg "Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.")